Literature DB >> 25610268

Unusually high prolactin level for medication-induced hyperprolactinemia: a case report.

Emin M Akbas1, Adem Gungor1, Cigdem Ozdemir1, Habib Bilen1.   

Abstract

Hyperprolactinemia has a number of etiologies, including physiological, pathological and pharmacological causes. Hyperprolactinemia is frequently associated with the use of certain medications. Patients using medications known to cause hyperprolactinemia generally develop a mild form of the condition, and the prolactin level rarely exceeds 100 ng/mL in these cases. We report a case of a 43-year-old woman with an extremely high prolactin level in medication-induced hyperprolactinemia caused by a combination of an antipsychotic (sulpirid) and an antidepressant (paroxetine).

Entities:  

Keywords:  Antidepressive agents; antipsychotic agents; hyperprolactinemia

Year:  2013        PMID: 25610268      PMCID: PMC4261487          DOI: 10.5152/eajm.2013.28

Source DB:  PubMed          Journal:  Eurasian J Med        ISSN: 1308-8734


  10 in total

Review 1.  Clinical practice. Prolactinoma.

Authors:  Janet A Schlechte
Journal:  N Engl J Med       Date:  2003-11-20       Impact factor: 91.245

Review 2.  Medication-induced hyperprolactinemia.

Authors:  Mark E Molitch
Journal:  Mayo Clin Proc       Date:  2005-08       Impact factor: 7.616

3.  Dopaminergic factors in human prolactin regulation: effects of neuroleptics and dopamine.

Authors:  G Langer; E J Sachar
Journal:  Psychoneuroendocrinology       Date:  1977-10       Impact factor: 4.905

4.  Metoclopramide stimulates prolactin secretion in man.

Authors:  R W McCallum; J R Sowers; J M Hershman; R A Sturdevant
Journal:  J Clin Endocrinol Metab       Date:  1976-06       Impact factor: 5.958

5.  The effects of olanzapine, risperidone, and haloperidol on plasma prolactin levels in patients with schizophrenia.

Authors:  S R David; C C Taylor; B J Kinon; A Breier
Journal:  Clin Ther       Date:  2000-09       Impact factor: 3.393

6.  Endocrinological features and endometrial morphology in climacteric women receiving hormone replacement therapy.

Authors:  A Grasso; F Baraghini; C Barbieri; E Dalla Vecchia; A M Previdi; G C Di Renzo; A Volpe
Journal:  Maturitas       Date:  1982-04       Impact factor: 4.342

Review 7.  Medical causes and consequences of hyperprolactinaemia. A context for psychiatrists.

Authors:  Richard I G Holt
Journal:  J Psychopharmacol       Date:  2008-03       Impact factor: 4.153

8.  Incidence of hyperprolactinemia during oral contraceptive therapy.

Authors:  J V Reyniak; M Wenof; J M Aubert; J J Stangel
Journal:  Obstet Gynecol       Date:  1980-01       Impact factor: 7.661

Review 9.  Prolactin and neuroleptic drugs.

Authors:  A I Green; W A Brown
Journal:  Endocrinol Metab Clin North Am       Date:  1988-03       Impact factor: 4.741

10.  Pharmacological causes of hyperprolactinemia.

Authors:  Daria La Torre; Alberto Falorni
Journal:  Ther Clin Risk Manag       Date:  2007-10       Impact factor: 2.423

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.